Table 1. Description of the included patients.
| Prednisone | Hydrocortisone | |||
|---|---|---|---|---|
| adenoma | CD | adenoma | CD | |
| Pathology | ||||
| Adrenocortical adenoma | 15/20 | 1/20 | 13/22 | 1/22 |
| Adrenoadenoma-like nodules | 1/20 | 1/20 | 1/22 | 2/22 |
| Adrenal nodular hyperplasia | 0/20 | 2/20 | 0/22 | 5/22 |
| Endocrinology | ||||
| LDDST no inhibition | 10/10 | 4/4 | 14/14 | 8/8 |
| HDDST no inhibition | 10/10 | 1 /4 | 14/14 | 3/8 |
| ACTH elevation | 0/16 | 4/4 | 0/14 | 8/8 |
| Average age | 37.1 (20–59) | 45.3 (28–54) | 41.5 (20–54) | 39.6 (29–51) |
| Lengths of disease (months) | 24.6 (1–96) | 32.8 (5–96) | 18.2 (0.5–72) | 22.4 (11–36) |
CD, Cushing's disease; LDDST, low dose dexamethasone suppression test; HDDST, high dose dexamethasone suppression test; ACTH, adrenocorticotropic hormone.